Immune-checkpoint blockade protects aged mice from infection

被引：0
|
作者：
Thiele, Daniel [1 ,2 ]
La Gruta, Nicole L. [1 ,2 ]
机构：
[1] Monash Univ, Immun Program, Clayton, Vic, Australia
[2] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia
来源：
NATURE AGING | 2024年 / 4卷 / 07期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
SENESCENCE;
D O I：
10.1038/s43587-024-00664-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A study demonstrates the efficacy of immune-checkpoint blockade in prolonging survival and boosting CD8+ T cell function in aged mice after pathogen exposure. These findings highlight how aging-related immune changes may lead to augmented CD8+ T cell responses to checkpoint blockade, which results in improved protection from infection. The findings also highlight the importance of understanding immune aging in future efforts to target immunotherapies to older adults.
引用
收藏
页码：907 / 908
页数：2
相关论文
共 50 条
  • [21] The cutting-edge progress of immune-checkpoint blockade in lung cancer
    Fei Zhou
    Meng Qiao
    Caicun Zhou
    Cellular & Molecular Immunology, 2021, 18 : 279 - 293
  • [22] Immune-checkpoint and hemopathies
    Burroni, Barbara
    Broudin, Chloe
    Damotte, Diane
    Laurent, Camille
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 101 - 110
  • [23] Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
    Huemer, Florian
    Leisch, Michael
    Geisberger, Roland
    Melchardt, Thomas
    Rinnerthaler, Gabriel
    Zaborsky, Nadja
    Greil, Richard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [24] IFNα Potentiates Immune-Checkpoint Blockade by Rewiring Metabolic Cross-talk
    Kao, Kung-Chi
    Jaccard, Alison
    Ho, Ping-Chih
    CANCER DISCOVERY, 2022, 12 (07) : 1615 - 1616
  • [25] Engineered nanoparticles circumvent the adaptive treatment tolerance to immune-checkpoint blockade therapy
    Weisheng Guo
    Lu Liu
    Chenyang Xiang
    Jingqi Chen
    XingJie Liang
    Science China(Chemistry), 2019, 62 (12) : 1557 - 1560
  • [26] Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
    Ye, Zengpanpan
    Ai, Xiaolin
    Yang, Kailin
    Yang, Zhengnan
    Fei, Fan
    Liao, Xiaoling
    Qiu, Zhixin
    Gimple, Ryan C.
    Yuan, Huairui
    Huang, Hao
    Gong, Yanqiu
    Xiao, Chaoxin
    Yue, Jing
    Huang, Liang
    Saulnier, Olivier
    Wang, Wei
    Zhang, Peidong
    Dai, Lunzhi
    Wang, Xin
    Wang, Xiuxing
    Ha Ahn, Young
    You, Chao
    Xu, Jianguo
    Wan, Xiaoxiao
    Taylor, Michael D.
    Zhao, Linjie
    Rich, Jeremy N.
    Zhou, Shengtao
    CANCER DISCOVERY, 2023, 13 (04) : 974 - 1001
  • [27] Engineered nanoparticles circumvent the adaptive treatment tolerance to immune-checkpoint blockade therapy
    Guo, Weisheng
    Liu, Lu
    Xiang, Chenyang
    Chen, Jingqi
    Liang, Xing-Jie
    SCIENCE CHINA-CHEMISTRY, 2019, 62 (12) : 1557 - 1560
  • [28] Dietary Lactobacillus-Derived Exopolysaccharide Enhances Immune-Checkpoint Blockade Therapy
    Kawanabe-Matsuda, Hirotaka
    Takeda, Kazuyoshi
    Nakamura, Marie
    Makino, Seiya
    Karasaki, Takahiro
    Kakimi, Kazuhiro
    Nishimukai, Megumi
    Ohno, Tatsukuni
    Omi, Jumpei
    Kano, Kuniyuki
    Uwamizu, Akiharu
    Yagita, Hideo
    Boneca, Ivo Gomperts
    Eberl, Gerard
    Aoki, Junken
    Smyth, Mark J.
    Okumura, Ko
    CANCER DISCOVERY, 2022, 12 (05) : 1336 - 1355
  • [29] Engineered nanoparticles circumvent the adaptive treatment tolerance to immune-checkpoint blockade therapy
    Weisheng Guo
    Lu Liu
    Chenyang Xiang
    Jingqi Chen
    Xing-Jie Liang
    Science China(Chemistry), 2019, (12) : 1557 - 1560
  • [30] Engineered nanoparticles circumvent the adaptive treatment tolerance to immune-checkpoint blockade therapy
    Weisheng Guo
    Lu Liu
    Chenyang Xiang
    Jingqi Chen
    Xing-Jie Liang
    Science China Chemistry, 2019, 62 : 1557 - 1560
12345